Esperion Therapeutics Inc (NAS:ESPR)
$ 2.8 0.33 (13.36%) Market Cap: 530.49 Mil Enterprise Value: 572.87 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Esperion Therapeutics Inc CLEAR Outcomes Company Update: Detailed Results Discussion Call Transcript

Mar 06, 2023 / 01:00PM GMT
Release Date Price: $5.08 (-19.95%)
Operator

Good day, and thank you for standing by. Welcome to the Clear Outcomes Data Shareholder Analyst Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Tiffany Aldrich, Associate Director, Corporate Communications. Please go ahead.

Tiffany Aldrich

Good morning, and welcome to Esperion's company update conference call. I'm Tiffany Aldrich, and I'm part of the Corporate Communications team here at Esperion.

I want to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in our March 4 press release and SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot